↓ Skip to main content

Is Maternal Use of Medicines during Pregnancy Associated with Deciduous Molar Hypomineralisation in the Offspring? A Prospective, Population-Based Study

Overview of attention for article published in Drug Safety, June 2013
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is Maternal Use of Medicines during Pregnancy Associated with Deciduous Molar Hypomineralisation in the Offspring? A Prospective, Population-Based Study
Published in
Drug Safety, June 2013
DOI 10.1007/s40264-013-0078-y
Pubmed ID
Authors

Marlies E. C. Elfrink, Henriette A. Moll, Jessica C. Kiefte-de Jong, Hanan El Marroun, Vincent W. V. Jaddoe, Albert Hofman, Bruno H. Stricker, Jacob M. ten Cate, Jaap S. J. Veerkamp

Abstract

The effects of maternal use of medicines during pregnancy on tooth development has scarcely been studied; only negative effects of tetracycline on tooth germs are known (irreversible tooth discoloration and enamel hypoplasia).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 17%
Student > Bachelor 10 14%
Student > Postgraduate 9 13%
Researcher 4 6%
Professor > Associate Professor 4 6%
Other 13 18%
Unknown 19 27%
Readers by discipline Count As %
Medicine and Dentistry 40 56%
Agricultural and Biological Sciences 3 4%
Nursing and Health Professions 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Business, Management and Accounting 1 1%
Other 2 3%
Unknown 22 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2013.
All research outputs
#15,274,524
of 22,714,025 outputs
Outputs from Drug Safety
#1,398
of 1,696 outputs
Outputs of similar age
#122,085
of 197,473 outputs
Outputs of similar age from Drug Safety
#24
of 29 outputs
Altmetric has tracked 22,714,025 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,696 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,473 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.